Endo International | ENDP - Ativo Circulante



Ativo Circulante Alterar Data
AbbVie USD 29.06B 523M 2025-12
Amarin USD 649.88M 21.55M 2025-12
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Coherus Biosciences USD 206.71M 254.25M 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
Merck USD 47.56B 10.49B 2025-09
Novartis USD 30.46B 2.26B 2025-12
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Phibro Animal Health USD 862.18M 26.39M 2025-12
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Takeda JPY 3.12T 195.82B 2025-12
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
Xeris Pharmaceuticals USD 240.31M 16.3M 2025-12
Zoetis USD 6.77B 185M 2025-12